Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
- 24 July 2010
- journal article
- case report
- Published by Springer Science and Business Media LLC in Breast Cancer
- Vol. 20 (4), 367-370
- https://doi.org/10.1007/s12282-010-0213-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral HepatitisKanzo, 2009
- Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during ChemotherapyAnnals of Internal Medicine, 2008
- Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and managementInternal Medicine Journal, 2007
- Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancerBritish Journal of Cancer, 2007
- Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignanciesBritish Journal of Haematology, 2007
- Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?Breast Cancer Research and Treatment, 2005
- Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patientsBreast Cancer Research and Treatment, 2004
- Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administrationLiver International, 2004
- Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignanciesJournal of Viral Hepatitis, 2004
- Prophylaxis Against Chemotherapy-Induced Reactivation of Hepatitis B Virus Infection With LamivudineJournal of Clinical Gastroenterology, 2003